Sable Therapeutics is a biotherapeutics company focused on fat cell re-engineering and was co-founded with a leading fat metabolism researcher at Columbia University Medical Center. We are leveraging novel scientific insights to target a variety of aesthetic indications that minimize fat volume while still preserving fat cell function.